Liver specialists' views on cancer risk tools for cured hepatitis C patients
Part of Cancer, Digestive system clinical trials.
This study asks liver specialists about their views on using non-invasive prediction models to estimate liver cancer risk in hepatitis C patients who have been cured. It aims to understand what helps or prevents them from using these tools.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a liver specialist (hepatologist).
- You have at least one year of experience treating patients with hepatitis C.
- You are not a general practitioner or a non-liver specialist.
- You are willing to complete a survey about your views on prediction tools.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have been cured of hepatitis C but still have liver scarring (cirrhosis) to see if certain factors can predict who might develop liver cancer later. It compares those who developed liver cancer with those who did not, to improve future screening.
This study is testing a new way to predict if people with chronic hepatitis B, who also have liver fibrosis or cirrhosis, might develop liver cancer (HCC). It uses your medical data to create a risk score, which could help you and your doctor plan earlier and more tailored monitoring.
This study aims to predict the risk of developing liver cancer in people with chronic liver conditions such as hepatitis B or C, cirrhosis, or fatty liver disease. By participating, you may help researchers improve early detection and prevention strategies for liver cancer.
This study looks back at medical records of people who had liver cancer (HCC) and had either a transplant or surgery to remove the tumor. It aims to improve a tool that helps predict how well a patient may do, which could guide future treatment decisions.
This study uses an AI tool to predict how liver cancer might come back after surgery. It is for people with early-stage liver cancer who are already scheduled for surgery and have recent MRI scans.
This trial uses a computer model to predict if your liver cancer might come back aggressively after surgery. If you are at high risk, you may receive additional treatment before surgery to lower that risk.
Hear when a new Non-invasive Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.